COLENA RATHBURN: Open Payments
NPI 1821637190 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$898 in 40 payments from 14 companies in 2025. Trend: 2023 $1,170 · 2024 $1,370 · 2025 $898
Food & beverage: $898
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $192 |
| Novo Nordisk Inc | 6 | $178 |
| ABBVIE INC. | 9 | $154 |
| Lilly USA, LLC | 4 | $77 |
| Astellas Pharma US Inc | 3 | $61 |
| Exact Sciences Corporation | 3 | $51 |
| PFIZER INC. | 3 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| Collegium Pharmaceutical, Inc. | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
Products named: AIRSUPRA, Wegovy, MOUNJARO, UBRELVY, QULIPTA, Veozah, BREZTRI, Cologuard Collection Kit.
Industry payments across IN — which companies pay providers there.
